Enlivex ENLV
NASDAQ ENLV
$0.20 -0.02 (-10.11%)
As of: Oct 21, 2026 · 3:46 PM EDT

Enlivex (ENLV) Operating Leases (2019 - 2026)

Updated

Enlivex's Operating Leases was $371,000 in Q2 2026.

Analysis

Enlivex (ENLV) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at Enlivex came in at $383,000, up 28.1% from FY2024.

  • Operating Leases shows a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
  • In earlier years, Operating Leases was $299,000 in FY2024 (-56.4%), $686,000 in FY2023 (-83.6%), $4.19 million in FY2022 (-22.2%) and $5.39 million in FY2021 (+980.0%).
  • The Q2 2026 figure marks the lowest quarterly Operating Leases since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 Enlivex 618,422.02 -48.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 371,000.00
Dec 31, 2025 383,000.00
Dec 31, 2024 299,000.00
Sep 30, 2023 3.82 Mn
Dec 31, 2022 4.19 Mn
Dec 31, 2021 5.39 Mn
Dec 31, 2020 499,000.00
Sep 30, 2020 499,000.00
Jun 30, 2020 236,000.00
Dec 31, 2019 298,000.00
API Access

Enlivex Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ENLV&period=max&api_key=YOUR_API_KEY